(R)-GNE-140, ≥99%

(R)-GNE-140

(R)-P7C3-OMe, 99.9%

(R)-P7C3-Ome

(S)-crizotinib, 99.9%

(S)-crizotinib

(R)-2-((S)-2-苯甲酰胺-3-(1H-吲哚-3-基)丙酰胺基)-3-苯基丙酸甲酯, 99%

Methyl benzoyl-L-tryptophyl-D-phenylalaninate

LGD-4033, 99%

LGD4033

Crassicauline A, 分析标准品,99%

Crassicauline A

(2R,2'R,3R,3'R,4S,4'S,5R,5'R,6S,6'S)-6,6'-硫代双(4-(4-(3-氟苯基)-1H-1,-1H-1,2,3-三唑-1-基)-2-(羟甲基)四氢-2H-吡喃-3,5-二醇), ≥98%

TD 139

((1,4-亚苯基双(亚甲基亚甲基))双(7,7-二甲基-2-氧代双环[2.2.1]庚烷-1-基-3-亚基))二甲磺酸钠, 98%

Sodium ((1,4-phenylenebis(methanylylidene))bis(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl-3-ylidene))dimethanesulfonate

(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺, 98%

(2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

(Z)-5-(4-羟基亚苄基)-3-异丁基-2-硫代噻唑烷-4-酮, 99%

(Z)-5-(4-Hydroxybenzylidene)-3-isobutyl-2-thioxothiazolidin-4-one

5-((3-氯苯基)胺)苯并-[c][2,6]萘啶-8-羧酸, ≥99%

5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid

NU7026, ≥99%

NU7026

YK-4-279, ≥99%

YK-4-279

4-羟基-6-甲基-3-(4-甲基-1-氧代戊基)-2H-吡喃-2-酮, 分析对照品,≥99%

4-Hydroxy-6-methyl-3-(4-methylpentanoyl)-2H-pyran-2-one

去甲异波尔定, 分析对照品,≥99%

Norisoboldine

亥茅酚苷, 分析标准品

Sec-O-Glucosylhamaudol

乙酰紫堇灵, ≥99%(HPLC)

Acetylcorynoline

塔拉萨敏, ≥99%（HPLC）

Talatisamine

ORY-1001, 99%

ORY-1001 (RG-6016) 2HCl

Pritelivir (BAY 57-1293), 99%

AIC316